---
title: "Patch nonwear explains over half of apparent nonadherence in a digital medicine system"
id: "medrxiv-16-patch-nonwear-accounts-for-more-than-half-of-apparent-nonadherence-in-a-digital"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-16-patch-nonwear-accounts-for-more-than-half-of-apparent-nonadherence-in-a-digital"
content_type: "clinical_feed_article"
specialty: "Pharmacology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.21.26363541v1?rss=1"
published_at: "2026-09-22T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Patch nonwear explains over half of apparent nonadherence in a digital medicine system
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-16-patch-nonwear-accounts-for-more-than-half-of-apparent-nonadherence-in-a-digital
- **Specialty:** [Pharmacology](https://medichelpline.com/clinical-feed/pharmacology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.21.26363541v1?rss=1)
- **Published At:** 2026-09-22T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Study analyzed 997 person-days from 20 outpatients prescribed **aripiprazole** using the Abilify MyCite digital medicine system, integrating ingestion records with wearable patch-contact data. - Among 322 days without a detected ingestion, 53.7% were days with insufficient **patch wear**, indicating that more than half of apparent nonadherence reflected device nonwear rather than confirmed missed doses. - If all no-detection days were counted as nonadherence, the apparent nonadherence rate was 32.3%; restricting to days with adequate wear reduced the measured nonadherence to 18.1%. - Because adherence during patch-off periods cannot be observed, the true nonadherence rate is bounded between 14.9% (lower bound) and 32.3% (upper bound) based on the available data. - Authors propose a three-state outcome classification: **detected ingestion**, no ingestion despite adequate wear (confirmed nonadherence), and patch-off or indeterminate days (unobserved adherence). - In the 744 days when the patch was worn, detected ingestion was more likely on days aligning with each participant's usual activity pattern (odds ratio 1.52, 95% credible interval 1.14–2.03) and on days with more time spent at home around the habitual dosing period (odds ratio 1.31, 1.04–1.64). - The behavioral associations are described as exploratory and characterize the context of medication-taking rather than implying causation. - The authors conclude that establishing device wear is integral to valid interpretation of adherence outcomes in **digital medicine systems**, and that passive behavioral sensing is most interpretable after confirming observation status. - IRB approval and informed consent were obtained; participant-level data are restricted due to privacy concerns but may be available to qualified researchers upon request.
## Clinical Analysis & Structured Key Points
Patch nonwear accounts for more than half of apparent nonadherence in a digital medicine system | medRxiv Skip to main content Patch nonwear accounts for more than half of apparent nonadherence in a digital medicine system View ORCID Profile Andrew Jin Soo Byun , Diana Chen , Haruka Notsu , Sunnie Li , View ORCID Profile Victoria Lisowski , Erlend Lane , Sean Ryan , John Torous doi: https://doi.org/10.64898/2026.09.21.26363541 Andrew Jin Soo Byun Beth Israel Deaconess Medical Center Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Andrew Jin Soo Byun For correspondence: jinsoobyun{at}g.harvard.edu Diana Chen Beth Israel Deaconess Medical Center Find this author on Google Scholar Find this author on PubMed Search for this author on this site Haruka Notsu Beth Israel Deaconess Medical Center Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sunnie Li Beth Israel Deaconess Medical Center Find this author on Google Scholar Find this author on PubMed Search for this author on this site Victoria Lisowski Beth Israel Deaconess Medical Center Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Victoria Lisowski Erlend Lane Beth Israel Deaconess Medical Center Find this author on Google Scholar Find this author on PubMed Search for this author on this site Sean Ryan Beth Israel Deaconess Medical Center Find this author on Google Scholar Find this author on PubMed Search for this author on this site John Torous Beth Israel Deaconess Medical Center Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Data/Code Preview PDF Abstract Digital-medicine systems can objectively confirm medication ingestion, but interpretation of a no-detection day depends on whether the wearable receiver was in contact with the body. We analyzed 997 person-days from 20 outpatients prescribed aripiprazole through Abilify MyCite by integrating ingestion records with patch-contact data; 17 participants also contributed smartphone sensing. Of 322 days without a detected ingestion, 53.7% had insufficient patch wear. Counting all no-detection days as nonadherent yielded an apparent nonadherence rate of 32.3%, whereas conditioning on adequate wear yielded 18.1%. Because adherence during patch-off periods is unobserved, the rate is bounded between 14.9% and 32.3%. These findings support a three-state outcome that distinguishes detected ingestion, no ingestion despite adequate wear, and patch-off or indeterminate days. Among 744 patch-worn days, detected ingestion was more likely on days that more closely matched each participant's usual activity pattern (odds ratio 1.52, 95% credible interval 1.14–2.03) and when participants spent more time at home around the habitual dose period (1.31, 1.04–1.64). These behavioral associations were exploratory and characterize the context of medication-taking rather than causal effects. Overall, device wear was integral to interpretation of the adherence outcome, and passive behavioral measures were most interpretable after observation status was established. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: The Beth Israel Deaconess Medical Center Institutional Review Board approved protocol 2023P-000628, and all participants provided written informed consent. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The participant-level data underlying this study cannot be made publicly available because they contain sensitive health information and high-resolution digital phenotyping data, including GPS-derived location information, that may pose a risk of participant re-identification. Public sharing is therefore restricted by the informed consent under which the data were collected and by institutional ethics requirements. De-identified data necessary to reproduce the reported findings may be made available to qualified researchers upon reasonable request, subject to approval by the Beth Israel Deaconess Medical Center Institutional Review Board and any applicable data-use agreements. Requests for data access may be directed to the corresponding author. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted September 22, 2026. Download PDF Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Patch nonwear accounts for more than half of apparent nonadherence in a digital medicine system Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Patch nonwear accounts for more than half of apparent nonadherence in a digital medicine system Andrew Jin Soo Byun , Diana Chen , Haruka Notsu , Sunnie Li , Victoria Lisowski , Erlend Lane , Sean Ryan , John Torous medRxiv 2026.09.21.26363541; doi: https://doi.org/10.64898/2026.09.21.26363541 Share This Article: Copy Citation Tools Patch nonwear accounts for more than half of apparent nonadherence in a digital medicine system Andrew Jin Soo Byun , Diana Chen , Haruka Notsu , Sunnie Li , Victoria Lisowski , Erlend Lane , Sean Ryan , John Torous medRxiv 2026.09.21.26363541; doi: https://doi.org/10.64898/2026.09.21.26363541 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (619) Allergy and Immunology (905) Anesthesia (336) Cardiovascular Medicine (4838) Dentistry and Oral Medicine (479) Dermatology (419) Emergency Medicine (651) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1634) Epidemiology (15986) Forensic Medicine (33) Gastroenterology (1206) Genetic and Genomic Medicine (7073) Geriatric Medicine (734) Health Economics (1067) Health Informatics (5074) Health Policy (1438) Health Systems and Quality Improvement (1780) Hematology (587) HIV/AIDS (1347) Infectious Diseases (except HIV/AIDS) (16316) Intensive Care and Critical Care Medicine (1177) Medical Education (674) Medical Ethics (155) Nephrology (727) Neurology (7318) Nursing (370) Nutrition (1088) Obstetrics and Gynecology (1245) Occupational and Environmental Health (1007) Oncology (3625) Ophthalmology (1058) Orthopedics (398) Otolaryngology (458) Pain Medicine (477) Palliative Medicine (140) Pathology (709) Pediatrics (1806) Pharmacology and Therapeutics (739) Primary Care Research (769) Psychiatry and Clinical Psychology (5927) Public and Global Health (9782) Radiology and Imaging (2438) Rehabilitation Medicine and Physical Therapy (1456) Respiratory Medicine (1250) Rheumatology (644) Sexual and Reproductive Health (774) Sports Medicine (582) Surgery (783) Toxicology (107) Transplantation (306) Urology (295)
## Related Clinical Research

- [Renewed Pharma and VC Interest in Osteoporosis Treatments After FDA Shift](https://medichelpline.com/clinical-feed/stat-news-1-stat-drugmakers-biotech-vcs-show-reinvigorated-interest-in-osteoporosis.md)
- [Lifestyle, Physical Activity, and Body Composition Differences in Women With Gestational Diabetes](https://medichelpline.com/clinical-feed/pubmed-42773636.md) (DOI: 10.12659/MSM.953627)
- [Nitric Oxide Dysregulation Links Metabolic Dysfunction to Cognitive Decline in Type 2 Diabetes](https://medichelpline.com/clinical-feed/pubmed-42746741.md) (DOI: 10.1042/BST20250325)
- [HHS and FDA push to reduce animal testing, endorse human-based research methods](https://medichelpline.com/clinical-feed/stat-news-0-stat-hhs-unveils-new-initiatives-to-reduce-animal-testing-in-drug-development.md)
- [Zero-Inflated Models Improve Pharmacovigilance Signal Detection in Sparse SRS Data](https://medichelpline.com/clinical-feed/medrxiv-5-finding-safety-signals-in-sparse-data-zero-inflated-models-for.md)

## Navigation
- [← Back to Pharmacology Feed](https://medichelpline.com/clinical-feed/pharmacology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.